Research Article
Volume 8 Issue 4 - 2021
Epidemiological and Clinical Risk Factorsfor Non-Erosive Reflux Disease, Erosive Esophagitis and Barrett’s Esophagus in Russia
Igor Maev1*, Igor Bakulin2, Dmitriy Bordin1,3,4, Nataliya Bakulina2, Inna Oganezova2, Yulia Embutnieks4, Roman Plavnik5, Lyudmila Fedulenkova4, Sergey Tikhonov2, Mariia Zhuravleva2 and Roman Vasiliev6
1Moscow State University of Medicine and Dentistry n.a. A.I. Yevdokimov, Moscow, Russia
2North-Western State Medical University n.a. I.I. Mechnikov, Saint-Petersburg, Russia
3Tver State Medical University, Tver, Russia
4SBHI Moscow clinical scientific and practical center n.a. A.S. Loginov of the Moscow Healthcare Department, Moscow, Russia
5Isocarb LLC, Moscow, Russia
6Multidisciplinary Clinic “Osnova”, Saint-Petersburg, Russia
*Corresponding Author: Igor Maev, Moscow State University of Medicine and Dentistry n.a. A.I. Yevdokimov, Moscow, Russia.
Received: January 05, 2021; Published: March 10, 2021




Abstract

The aim of the study: Was to identify the epidemiological and clinical factors predisposing to non-erosive reflux disease (NERD), erosive esophagitis (EE) and Barrett’s esophagus in Russian population of patients.

Materials and Methods: 1433 patients with GERD from Moscow, Moscow region, St. Petersburg and Leningrad region were studied. During the study complaints and anamnestic data were gathered, anthropometry, tests for H. pylori infection and upper endoscopy were performed. Spearman rank correlation was used to identify the correlation of clinical characteristics with NERD, EE and Barrett’s esophagus. 880 patients with GERD (407 with NERD, 443 with EE, 27 with Barrett’s esophagus, 3 with esophageal stricture) were selected for correlation analysis due to the presence of all necessary parameters.

Results: The prevalence of two main GERD phenotypes - EE and NERD - was approximately equal in the patients of Russian megapolises. Male gender was significantly negatively correlated with NERD development (p = 0.002011). An inverse correlation was found between NERD and older age groups (p = 0.002459), high waist circumference (WC) (p = 0.003733), long duration of GERD symptoms (p = 0.012984), the results of the GerdQ ≥ 8 points (p = 0.040030). In the group of patients with EE grade A-B, a significant inverse correlation was revealed with age over 40 years (p = 0.002708), high body mass index (BMI) (p = 0.020957), and high WC (p = 0.001293). The male gender (p = 0.000108) and the duration of GERD symptoms more than 3 years (p = 0.028292) were significantly associated with severe grades of EE development. The male gender (p = 0.007505) and not using of PPIs over the past 6 months (p = 0.015930) were positively associated with Barrett's esophagus.

Conclusion: Female gender, young age, normal BMI and WC, short duration of symptoms and GERD-Q less than 7 points were positively associated with NERD compared with EE among Russian patients. Male patients with long-term GERD symptoms who do not take PPIs are at high risk of Barrett's esophagus.

Keywords: Gastroesophageal Reflux Disease (GERD); Erosive Esophagitis (EE); Non-Erosive Reflux Disease (NERD); Proton Pump Inhibitors (PPIs); Heartburn, Barrett’s Esophagus

References

    1. Gyawali CP., et al. “Modern diagnosis of GERD: the Lyon Consensus”. Gut 67 (2018): 1351-1362.
    2. Ribolsi M., et al. “New classifications of gastroesophageal reflux disease: an improvement for patient management?”. Expert Review of Gastroenterology and Hepatology 8 (2019): 761-769.
    3. Lazebnik LB., et al. “Results of a multicenter trial "Epidemiology of Gastroesophageal Reflux Disease in Russia" (MEGRE)”. Terapevticheskii Arkhiv 1 (2011): 45-50.
    4. Nina Bandyopadhyay., et al. “Pocket Handbook of Esophageal Disorders. Chapter 11. Gastroesophageal Reflux Disease (GERD). Springer Nature Switzerland AG (2019): 85.
    5. Bakulin IG., et al. “Phenotypes od Gastroesophageal Reflux Disease in real clinical practice”. Consilium Medicum 8 (2019): 15-22.
    6. Vakil N., et al. “The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus”. The American Journal of Gastroenterology 101 (2006): 1900-1920.
    7. Miwa H., et al. “Esophageal sensation and esophageal hypersensitivity - overview from bench to bedside”. Journal of Neurogastroenterology and Motility 16 (2010): 353-362.
    8. Dickman R., et al. “The role of pain modulators in esophageal disorders - no pain no gain”. Neurogastroenterology and Motility 26 (2014): 603-610.
    9. Hiltz SW., et al. “AGA Medical Position Statement on the Management of Gastroesophageal Reflux Disease”. Gastroenterology 135 (2008): 1385-1391.
    10. Katz PO., et al. “ACG practice guidelines for the diagnosis and management of gastroesophageal reflux disease”. The American Journal of Gastroenterology 108 (2013): 308-328.
    11. Fock KM., et al. “Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus”. Gut 65 (2016): 1402-1415.
    12. Roman S., et al. “Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group”. Neurogastroenterology and Motility 29 (2017): 1-15.
    13. Zakharova NV., et al. “Prevalence of Helicobacter pylori infection in gastroenterological patients in Saint-Petersburg”. Pharmateca 5 (2016): 33-39.
    14. Bakulinа N., et al. “Epidemiological study on Helicobacter pylori infection among patients with dyspepsia in Saint-Petersburg (Russia)”. Helicobacter1 (2018): e12525.
    15. Bakulinа N., et al. “Prevalence of H. pylori infection among physicians”. Experimental and Clinical Gastroenterology 12 (2017): 20-24.
    16. Mari A., et al. “Demographics and Clinical and Endoscopic Characteristics of Patients with Helicobacter pylori Infection and Gastroesophageal Reflux Disease: A Case-Control Study”. Gastroenterology Research and Practice (2019): 3819893.
    17. Mazzoleni F., et al. “Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD)”. International Journal of Obesity (2019).
    18. Jiyuan AN. “Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases”. Nature Communications (2019).
    19. Jang SH., et al. “Psychological factors influence the gastroesophageal reflux disease (GERD) and their effect on quality of life among firefighters in South Korea”. International Journal of Occupational and Environmental Health 4 (2016): 315-320.
    20. Melissa Schmidt., et al. “Epidemiological risk factors in a comparison of a Barrett Esophagus Registry (BarretNET) and a case control population in Germany”. Cancer Prevention Research (2020).
    21. Blackshaw LA., et al. “Pharmacologic treatments for esophageal disorders”. Annals of the New York Academy of Sciences 1 (2014): 23-39.
    22. Boeckxstaens GE and Smout A. “Systemic review: role of acid, weakly acid and weakly alkaline reflux in gastro-oesophageal reflux disease”. Alimentary Pharmacology Therapeutics 3 (2010): 334-343.
    23. Cicala M., et al. “Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease”. World Journal of Gastroenterology 39 (2013): 6529-6535.
    24. Furuta T., et al. “CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole”. European Journal of Clinical Pharmacology 7 (2009): 693-698.
    25. Richter JE. “How to manage refractory GERD”. Nature Clinical Practice Gastroenterology and Hepatology 4 (2007): 658-664.

     

Citation: Igor Maev., et al. “Epidemiological and Clinical Risk Factorsfor Non-Erosive Reflux Disease, Erosive Esophagitis and Barrett’s Esophagus in Russia”. EC Gastroenterology and Digestive System 8.4 (2021): 01-09.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 24, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk